What lessons can be learnt from withdrawal of mibefradil from the market?
Authors:
- Alain Li Wan PoAPAlain Li Wan Po
- Wy ZhangWZWy Zhang
- 1 June 1998
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 351 (9119) , 1829-1830
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Calcium channel blockersBMJ, 1998
- Too soon to marketBMJ, 1997
- Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleedingJournal of Human Hypertension, 1997
- Cost of innovation in the pharmaceutical industryJournal of Health Economics, 1991